‘Ant-Man and the Wasp: Quantumania’ box office suffered steep decline in second week

‘Ant-Man and the Wasp: Quantumania’ box office suffered steep decline in second week


Marvel Studios’ “Ant-Man and the Wasp: Quantumania.”

Disney

Not every Marvel movie can be “Avengers: Endgame.”

That’s the sentiment from box office analysts after the Marvel Cinematic Universe’s latest film “Ant-Man and the Wasp: Quantumania” saw the sharpest decline in ticket sales from opening weekend to second weekend in franchise history.

After securing $106.1 million during its first Friday, Saturday, Sunday in domestic theaters, the Disney film tallied just $31.9 million over the weekend, a 69.8% decline.

“This is a decline somewhat sharper than expected, but we also shouldn’t make a mountain from a mole hill,” said Shawn Robbins, chief analyst at BoxOffice.com. “Marvel films have been trending more and more frontloaded for years now, and that’s perhaps compounded slightly by the reality that theaters are now charging more for opening weekend tickets than subsequent days and weeks.”

To be sure, “Quantumania” is one of the worst reviewed Marvel films, with a 48% “rotten” critics’ score on Rotten Tomatoes. However, fans appeared to have enjoyed the film, generating an 83% audience rating.

Still, blockbuster features often see a significant decline from the first weekend to the second, as pent up demand drives moviegoers to see films as soon as they open. Marvel’s other 30 films range from a 44% drop for 2018’s “Black Panther” to a 67.8% drop for the pandemic released “Black Widow.”

“Thor: Love and Thunder,” “Doctor Strange in the Multiverse of Madness” and “Spider-Man: No Way Home,” a co-production with Sony, all saw second week drops in excess of 67%.

“Love and Thunder” went on to collect $760 million globally, “Multiverse of Madness” snared $952 million during its worldwide run and “No Way Home” nearly reached $2 billion in ticket sales.

“In the grand scheme of things, Marvel is still on some of the surest footing of any franchise in history,” Robbins said.

The film also has more counter-programming than other Marvel films released in the last few years. During the pandemic, films could run for weeks without any direct competition or other theatrical releases. Now, studios are offering up a steadier stream of content and audiences have more choices.

Over the weekend, Universal’s “Cocaine Bear” sniffed up $23 million. The R-rated horror-comedy saw 63% of its ticket sales from the 18- to 34-year-old demographic, the same group that often comes out for big budget superhero flicks.

“Universal may not have had success with Dark Universe, but their Snark Universe is alive and well,” said Jeff Bock, senior analyst at Exhibitor Relations.

He pointed to “Violent Night” and “M3gan,” in addition to “Cocaine Bear,” as films that have outperformed expectations at the box office. This showcases that audiences are interested in a diversity of genres and are coming out to cinemas to see them.

“‘Cocaine Bear’ jumped into the public consciousness seemingly overnight and rode a wave of interest, and incredulity, to overperform this weekend with its grindhouse sensibilities,” said Paul Dergarabedian, senior media analyst at Comscore. “[It attracted] an enthusiastic audience hungry for something out of the ordinary.”

Additionally, Lionsgate’s “Jesus Revolution” catered to faith-based audiences and drummed up $15.5 million over the weekend.

“Clearly there is a demand for movies of all types and this weekend showed how a diverse selection of films can drive traffic to the movie theater,” Dergarabedian said.

Disclosure: Comcast is the parent company of NBCUniversal and CNBC. NBCUniversal is the distributor of “Cocaine Bear,” “Violent Night” and “M3gan.” NBCUniversal also owns Rotten Tomatoes.



Source

FDA approves Eli Lilly’s GLP-1 pill, opening the next phase of the weight loss drug market
Business

FDA approves Eli Lilly’s GLP-1 pill, opening the next phase of the weight loss drug market

The U.S. Food and Drug Administration approved Eli Lilly‘s GLP-1 pill, the company said, a major milestone for the Indianapolis-based drugmaker and one that will test the market for new weight-loss medications. Lilly said the once-daily pill, Foundayo, will start shipping from direct-to-consumer platform LillyDirect on Monday and will be available at pharmacies and on […]

Read More
Apartment rents weaken further as war and job cuts weigh on demand
Business

Apartment rents weaken further as war and job cuts weigh on demand

Key Points March rents were down 1.7% on an annual basis, according to Apartment List. That’s the largest drop since Apartment List began tracking in 2017and larger than the record set in the early months of the Covid pandemic. Rents are falling because vacancies are also unusually high. A version of this article first appeared […]

Read More
Volkswagen deal with EV maker Xpeng shows how China tech threatens Western automakers
Business

Volkswagen deal with EV maker Xpeng shows how China tech threatens Western automakers

In 1984, Volkswagen partnered with a Chinese automaker because it was required by Chinese law. Now the German company is partnering with Chinese automakers because it wants to use their technology. Volkswagen Group today maintains the original joint ventures it made with Chinese automakers in those early days of its foray into what has become […]

Read More